These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
858 related articles for article (PubMed ID: 10476222)
1. Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigen. Tüting T; Gambotto A; Robbins PD; Storkus WJ; DeLeo AB Gene Ther; 1999 Apr; 6(4):629-36. PubMed ID: 10476222 [TBL] [Abstract][Full Text] [Related]
2. Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer. Song K; Chang Y; Prud'homme GJ Gene Ther; 2000 Mar; 7(6):481-92. PubMed ID: 10757021 [TBL] [Abstract][Full Text] [Related]
3. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
4. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation. Gieni RS; Yang X; Kelso A; Hayglass KT Immunology; 1996 Jan; 87(1):119-26. PubMed ID: 8666423 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of recombinant adenovirus as vector for allergen gene therapy in a mouse model of type I allergy. Sudowe S; Montermann E; Steitz J; Tüting T; Knop J; Reske-Kunz AB Gene Ther; 2002 Jan; 9(2):147-56. PubMed ID: 11857073 [TBL] [Abstract][Full Text] [Related]
6. Uptake and presentation of exogenous antigen and presentation of endogenously produced antigen by skin dendritic cells represent equivalent pathways for the priming of cellular immune responses following biolistic DNA immunization. Sudowe S; Dominitzki S; Montermann E; Bros M; Grabbe S; Reske-Kunz AB Immunology; 2009 Sep; 128(1 Suppl):e193-205. PubMed ID: 18800984 [TBL] [Abstract][Full Text] [Related]
7. Induction of antigen-specific Th1-biased immune responses by plasmid DNA in schistosoma-infected mice with a preexistent dominant Th2 immune profile. Ayash-Rashkovsky M; Weisman Z; Zlotnikov S; Raz E; Bentwich Z; Borkow G Biochem Biophys Res Commun; 2001 Apr; 282(5):1169-76. PubMed ID: 11302738 [TBL] [Abstract][Full Text] [Related]
8. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
9. Gene-gun biolistic immunization encoding glutamic acid decarboxylase: a model for studying Langerhans cell abnormalities and mimicry in the nonobese diabetic mouse. Joussemet B; Vu AT; Sai P; Bach JM Ann N Y Acad Sci; 2005 Jun; 1051():613-25. PubMed ID: 16127002 [TBL] [Abstract][Full Text] [Related]
10. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma. Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252 [TBL] [Abstract][Full Text] [Related]
11. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. Chow YH; Chiang BL; Lee YL; Chi WK; Lin WC; Chen YT; Tao MH J Immunol; 1998 Feb; 160(3):1320-9. PubMed ID: 9570550 [TBL] [Abstract][Full Text] [Related]
13. LFA-3 plasmid DNA enhances Ag-specific humoral- and cellular-mediated protective immunity against herpes simplex virus-2 in vivo: involvement of CD4+ T cells in protection. Sin JI; Kim J; Dang K; Lee D; Pachuk C; Satishchandran C; Weiner DB Cell Immunol; 2000 Jul; 203(1):19-28. PubMed ID: 10915558 [TBL] [Abstract][Full Text] [Related]
14. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector. Juillard V; Villefroy P; Godfrin D; Pavirani A; Venet A; Guillet JG Eur J Immunol; 1995 Dec; 25(12):3467-73. PubMed ID: 8566039 [TBL] [Abstract][Full Text] [Related]
15. Gene gun administration of therapeutic HPV DNA vaccination restores the efficacy of prolonged defrosted viral based vaccine. Lin CT; Yen CF; Shaw SW; Yen TC; Chen YJ; Soong YK; Lai CH Vaccine; 2009 Dec; 27(52):7352-8. PubMed ID: 19781679 [TBL] [Abstract][Full Text] [Related]
16. Prevention of long-term IgE antibody production by gene gun-mediated DNA vaccination. Ludwig-Portugall I; Montermann E; Kremer A; Reske-Kunz AB; Sudowe S J Allergy Clin Immunol; 2004 Oct; 114(4):951-7. PubMed ID: 15480341 [TBL] [Abstract][Full Text] [Related]
17. Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization. Westermann J; Nguyen-Hoai T; Mollweide A; Richter G; Schmetzer O; Kim HJ; Blankenstein T; Dörken B; Pezzutto A Gene Ther; 2004 Jul; 11(13):1048-56. PubMed ID: 15085174 [TBL] [Abstract][Full Text] [Related]
18. Plasmid DNA vaccines are effective in the absence of IFNgamma. Hassett DE; Zhang J; Whitton JL Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092 [TBL] [Abstract][Full Text] [Related]